Opportunity Information: Apply for RFA AI 14 028

  • The National Institutes of Health in the health sector is offering a public funding opportunity titled "Modeling Immunity for Biodefense (U19)" and is now available to receive applicants.
  • Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.855 Allergy and Infectious Diseases Research 93.856 Microbiology and Infectious Diseases Research.
  • This funding opportunity was created on Mar 21, 2014 and posted on Mar 21, 2014.
  • Applicants must submit their applications by Jul 18, 2014. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
  • The funding agency has allocated a total of $6,000,000.00 to eligible and selected applicants.
  • Each selected applicant is eligible to receive up to $1,000,000.00 in funding.
  • Eligible applicants include: County governments Small businesses State governments City or township governments Native American tribal governments (Federally recognized) Special district governments Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Private institutions of higher education Others (see text field entitled Additional Information on Eligibility for clarification) For profit organizations other than small businesses Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education.
  • Other Eligible Applicants include the following Alaska Native and Native Hawaiian Serving Institutions Asian American Native American Pacific Islander Serving Institutions (AANAPISISs) Eligible Agencies of the Federal Government Faith based or Community based Organizations Hispanic serving Institutions Historically Black Colleges and Universities (HBCUs) Indian/Native American Tribal Governments (Other than Federally Recognized) Regional Organizations Tribally Controlled Colleges and Universities (TCCUs) U.S. Territory or Possession Foreign components, as defined in the NIH Grants Policy Statement, are allowed.
Apply for RFA AI 14 028

[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:

Opportunity Summary:

The Modeling Immunity for Biodefense (U19) grant opportunity (Funding Opportunity Number RFA-AI-14-028) is a National Institutes of Health (NIH) cooperative agreement designed to build a coordinated network of research teams that develop and test computational models of immune responses to infectious diseases, explicitly excluding HIV/AIDS. The program focuses on immunity in two broad contexts: immune responses that occur during or after an infection, and immune responses measured before and after vaccination. What makes this opportunity distinctive is that it is not looking for modeling work in isolation. Instead, it emphasizes an iterative loop where computational modeling informs immunological experiments, and experimental results then feed back into the models to improve their accuracy, robustness, and usefulness.

At its core, the FOA is aiming to push the field toward a more predictive and mechanistic understanding of how complex immune processes unfold in real biological settings relevant to biodefense. Applicants are expected to go beyond descriptive analyses and instead develop, refine, and validate models that can help explain immune mechanisms and potentially anticipate outcomes such as protection, susceptibility, or immune dynamics over time. The intent is that these models become practical tools for studying infectious disease immunity and vaccination responses, not just academic demonstrations. Because the award mechanism is a cooperative agreement (U19), NIH typically expects substantial involvement in program coordination, collaboration across groups, and shared objectives that align with the networked nature of the initiative.

A major secondary goal is broad community impact through openness and reuse. The FOA specifically calls for computational models and the data generated under the program to be made readily available to other researchers for further refinement or direct application in biological experimentation. In other words, the expectation is that funded teams will produce resources the wider community can pick up and build upon, accelerating progress beyond the funded consortium itself. To reinforce this community-building aspect, the program also supports pilot projects as well as workshops and symposia, which are meant to encourage adoption of computational immunity approaches, cross-pollination between modelers and experimental immunologists, and the spread of best practices.

From an administrative and funding standpoint, this was a discretionary NIH funding opportunity in the health research category, tied to CFDA numbers 93.855 (Allergy and Infectious Diseases Research) and 93.856 (Microbiology and Infectious Diseases Research). The FOA listed an estimated total funding amount of $6,000,000 with an award ceiling of $1,000,000, and it did not require cost sharing or matching. The posting date and creation date were both March 21, 2014, with an original and current closing date of July 18, 2014, and an archive date of August 18, 2014. While those dates indicate the specific announcement is historical, the structure and aims are representative of NIH efforts to integrate computational and experimental immunology in areas relevant to biodefense and emerging infectious diseases.

Eligibility was broad and included many types of domestic organizations and institutions. Eligible applicants included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including both 501(c)(3) and certain non-501(c)(3) entities), for-profit organizations (including small businesses and other for-profits), and various levels of government such as state, county, city or township governments, special district governments, and independent school districts. Tribal governments and tribal organizations were included, both federally recognized and other-than-federally recognized entities, along with tribally controlled colleges and universities. The FOA also highlighted eligibility for organizations such as Historically Black Colleges and Universities (HBCUs), Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, AANAPISIs, and faith-based or community-based organizations, among others. Importantly, foreign components were allowed as defined in the NIH Grants Policy Statement, which signaled openness to international collaboration when it meaningfully contributed to the project goals.

In practical terms, a strong application under this FOA would be expected to propose a coherent, multi-project program that connects computational modeling tightly with experimental validation. It would likely include plans for data stewardship and model dissemination so that outputs are usable by others, not locked behind proprietary workflows. It would also fit naturally into the network concept by showing how the team would collaborate, share resources, and contribute to collective progress in modeling immunity for infectious disease and biodefense-relevant questions.

For full details, NIH referenced the official announcement page at: http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-028.html, and provided NIH Office of Extramural Research (OER) webmaster contacts for access or linking issues (FBOWebmaster@OD.NIH.GOV).

Frequently Asked Questions (FAQs): Modeling Immunity for Biodefense (U19) - RFA-AI-14-028

What is the Modeling Immunity for Biodefense (U19) funding opportunity?

Modeling Immunity for Biodefense (U19) is a National Institutes of Health (NIH) cooperative agreement program (Funding Opportunity Number RFA-AI-14-028) intended to build a coordinated network of research teams that develop and test computational models of immune responses to infectious diseases relevant to biodefense.

Which NIH award mechanism is used, and what does that imply?

The FOA uses a U19 cooperative agreement mechanism. This implies substantial NIH involvement in program coordination and an expectation of collaboration across groups, shared objectives, and participation consistent with a networked research initiative.

What scientific areas does this FOA focus on?

The FOA focuses on computational modeling of immunity in two broad contexts: (1) immune responses that occur during or after an infection, and (2) immune responses measured before and after vaccination.

Are HIV/AIDS projects allowed under this opportunity?

No. The opportunity explicitly excludes HIV/AIDS.

Is this opportunity only for computational model development?

No. A central requirement is an iterative loop where computational modeling informs immunological experiments, and experimental results then feed back into the models to improve their accuracy, robustness, and usefulness.

What is meant by an "iterative loop" between modeling and experiments?

It refers to a cycle in which model outputs guide experimental design or measurement, and experimental findings are then used to refine, validate, and strengthen the computational models.

What is the overall goal of the FOA?

The FOA aims to move the field toward a more predictive and mechanistic understanding of complex immune processes as they unfold in real biological settings relevant to biodefense and infectious disease immunity.

Does the FOA emphasize descriptive analyses or predictive/mechanistic models?

The FOA emphasizes models that go beyond descriptive analyses, favoring predictive and mechanistic approaches that can help explain immune mechanisms and potentially anticipate outcomes such as protection, susceptibility, or immune dynamics over time.

What kinds of outcomes are models expected to help anticipate?

Based on the FOA description, models are intended to potentially anticipate outcomes such as protection, susceptibility, and immune dynamics over time.

How does biodefense relate to the program's intent?

The program is positioned to support biodefense-relevant research by improving practical, validated modeling tools for immunity to infectious diseases and vaccination responses in settings relevant to biodefense and emerging infectious diseases.

Is community access to models and data expected?

Yes. A major goal is broad community impact through openness and reuse. The FOA calls for computational models and data generated under the program to be made readily available to other researchers for refinement or direct application in biological experimentation.

What does "readily available" mean in the context of this FOA?

The FOA indicates an expectation that models and program-generated data can be accessed and reused by other researchers rather than being restricted to proprietary or closed workflows.

Does this program support activities beyond the main research projects?

Yes. The program supports pilot projects as well as workshops and symposia intended to encourage adoption of computational immunity approaches, collaboration between modelers and experimental immunologists, and dissemination of best practices.

What is the estimated total funding and the maximum award size listed?

The FOA listed an estimated total funding amount of $6,000,000 and an award ceiling of $1,000,000.

Is cost sharing or matching required?

No. The FOA stated that cost sharing or matching was not required.

What is the funding category and the relevant CFDA numbers?

This was a discretionary NIH funding opportunity in the health research category associated with CFDA 93.855 (Allergy and Infectious Diseases Research) and CFDA 93.856 (Microbiology and Infectious Diseases Research).

When was this FOA posted, and what were the key dates?

The posting date and creation date were March 21, 2014. The original and current closing date was July 18, 2014. The archive date was August 18, 2014.

Is this specific announcement still open?

No. The dates provided indicate it was a historical announcement that closed on July 18, 2014 and was archived on August 18, 2014.

What types of applicant organizations were eligible?

Eligibility was broad and included public and state-controlled institutions of higher education, private institutions of higher education, nonprofits (including 501(c)(3) and certain non-501(c)(3) entities), for-profit organizations (including small businesses), and multiple levels of government (state, county, city or township, special district governments, and independent school districts).

Were tribal entities eligible?

Yes. Federally recognized tribal governments and other-than-federally recognized tribal governments were included, as well as tribal organizations and tribally controlled colleges and universities.

Were minority-serving institutions and community/faith-based organizations mentioned as eligible?

Yes. The FOA highlighted eligibility for organizations such as HBCUs, Hispanic-serving institutions, Alaska Native and Native Hawaiian-serving institutions, AANAPISIs, and faith-based or community-based organizations, among others.

Are foreign components permitted under this FOA?

Yes. Foreign components were allowed as defined in the NIH Grants Policy Statement, indicating openness to international collaboration when it meaningfully contributes to the project goals.

What kind of program structure would be considered strong for this FOA?

Based on the description, a strong application would propose a coherent, multi-project program that tightly connects computational modeling with experimental validation, includes plans for data stewardship and model dissemination, and fits the network concept through collaboration and resource sharing.

Where can the official NIH announcement be found?

NIH referenced the official announcement page at http://grants.nih.gov/grants/guide/rfa-files/RFA-AI-14-028.html.

Who is the contact for access or linking issues related to the NIH page?

The NIH Office of Extramural Research (OER) webmaster contact provided for access or linking issues is FBOWebmaster@OD.NIH.GOV.

Browse more opportunities from the same agency: National Institutes of Health

Browse more opportunities from the same category: Health

Next opportunity: WaterSMART Title XVI Feasibility Studies for Fiscal Year 2014

Previous opportunity: Accelerating Medicines Partnership (AMP) in Rheumatoid Arthritis and Lupus Network Research Sites (UH2/UH3)

USGrants.org Applicant Portal:

Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.

Apply for RFA AI 14 028

 

[Watch] how do funding administrators access proposals?

Applicants also applied for:

Applicants who have applied for this opportunity (RFA AI 14 028) also looked into and applied for these:

Funding Opportunity
CDCs National Undergraduate Student Program A Public Helath Workplace Experience to Increase Student Interest in Public Health Apply for CDC RFA MN11 110104CONT14

Funding Number: CDC RFA MN11 110104CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Building Capacity and Networks to Address Emerging Infectious Diseases in the Americas Apply for CDC RFA CK13 130102CONT14

Funding Number: CDC RFA CK13 130102CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Leveraging a Recovery Act Resource to Accelerate Research on Neurodevelopment (R01) Apply for RFA MH 15 400

Funding Number: RFA MH 15 400
Agency: National Institutes of Health
Category: Health
Funding Amount: $350,000
Provider Education and Public Awareness about Primary Immunodeficiency Disease Apply for CDC RFA OE12 120303CONT14

Funding Number: CDC RFA OE12 120303CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Targeting Latently Infected Cells Without Reactivation (R01) Apply for RFA AI 14 021

Funding Number: RFA AI 14 021
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
National Center for HIV, Viral Hepatitis, STD and TB Prevention (NCHHSTP) Apply for CDC RFA PS13 131502CONT14

Funding Number: CDC RFA PS13 131502CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
NIAID Division of Allergy, Immunology and Transplantation Statistical and Clinical Coordinating Center (UM2) Apply for RFA AI 14 016

Funding Number: RFA AI 14 016
Agency: National Institutes of Health
Category: Health
Funding Amount: $16,500,000
National Environmental Medicine Education and Consultation Project (NEMECP) Apply for CDC RFA TS14 1401

Funding Number: CDC RFA TS14 1401
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
Reduce Hepatitis Infections by Treatment and Integrated Prevention Services (Hepatitis TIPS) among Non urban Young Persons Who Inject Drugs Apply for RFA PS 14 004

Funding Number: RFA PS 14 004
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $300,000
National Diabetes Prevention Program Preventing Type 2 Diabetes Among People at High Risk Apply for CDC RFA DP12 121203CONT14

Funding Number: CDC RFA DP12 121203CONT14
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
High Impact Neuroscience Research Resource Grants (R24) Apply for RFA NS 14 006

Funding Number: RFA NS 14 006
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Clinical Studies of Mental Illness Not Involving Treatment Development, Efficacy, or Effectiveness Trials (Collaborative R01) Apply for PAR 14 165

Funding Number: PAR 14 165
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
Service Area Competition Additional Area (SAC AA) Warrenton, GA Apply for HRSA 14 136

Funding Number: HRSA 14 136
Agency: Health Resources and Services Administration
Category: Health
Funding Amount: $1,185,045
Biology of Manual Therapies (R21) Apply for PA 14 167

Funding Number: PA 14 167
Agency: National Institutes of Health
Category: Health
Funding Amount: $200,000
Biology of Manual Therapies (R01) Apply for PA 14 168

Funding Number: PA 14 168
Agency: National Institutes of Health
Category: Health
Funding Amount: Case Dependent
The Affordable Care Act and What it Means for People with Disabilities Apply for NCD0114

Funding Number: NCD0114
Agency: National Council on Disability
Category: Health
Funding Amount: $135,000
Fetal Alcohol Spectrum Disorders Practice and Implementation Centers Apply for CDC RFA DD14 1402

Funding Number: CDC RFA DD14 1402
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $275,000
Improving Fetal Alcohol Spectrum Disorders Prevention and Practice through National Partnerships Apply for CDC RFA DD14 1403

Funding Number: CDC RFA DD14 1403
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: Case Dependent
COMPREHENSIVE COMMUNITY HIV PREVENTION PROJECT FOR KEY AND VULNERABLE POPULATIONS (CP2) Apply for RFI CP2 TANZANIA

Funding Number: RFI CP2 TANZANIA
Agency: Agency for International Development
Category: Health
Funding Amount: $74,999,999
Evaluation of Health Promotion and Prevention Programs for Blood Disorders Apply for CDC RFA DD14 1405

Funding Number: CDC RFA DD14 1405
Agency: Centers for Disease Control and Prevention
Category: Health
Funding Amount: $600,000

 

Grant application guides and resources

It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!

Apply for Grants

 

USGrants.org applicant portal membership

 

Premium leads for funding administrators, grant writers, and loan issuers

Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.

If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.

Subscribe to Leads

 

Request more information:

Would you like to learn more about this funding opportunity, similar opportunities to "RFA AI 14 028", eligibility, application service, and/or application tips? Submit an inquiry below:

Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.